Literature DB >> 17526088

Prevention of death in COPD.

Carlo La Vecchia, Leonardo M Fabbri.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17526088

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

1.  Questionable research and marketing of a combination drug for smoker's lungs.

Authors:  Peter Christian Gøtzsche
Journal:  J R Soc Med       Date:  2014-07-10       Impact factor: 5.344

Review 2.  Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective.

Authors:  K Suresh Babu; Jack A Kastelik; Jaymin B Morjaria
Journal:  Br J Clin Pharmacol       Date:  2014-08       Impact factor: 4.335

Review 3.  Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents.

Authors:  Donald P Tashkin; Leonardo M Fabbri
Journal:  Respir Res       Date:  2010-10-29

4.  Pneumonia in elderly patients with chronic obstructive pulmonary disease.

Authors:  Pierre Ernst; Samy Suissa
Journal:  Curr Infect Dis Rep       Date:  2008-05       Impact factor: 3.725

Review 5.  Corticosteroid resistance and novel anti-inflammatory therapies in chronic obstructive pulmonary disease: current evidence and future direction.

Authors:  Amir Hakim; Ian M Adcock; Omar S Usmani
Journal:  Drugs       Date:  2012-07-09       Impact factor: 9.546

6.  Randomized Trials Built on Sand: Examples from COPD, Hormone Therapy, and Cancer.

Authors:  Samy Suissa
Journal:  Rambam Maimonides Med J       Date:  2012-07-31

Review 7.  Insights into interventions in managing COPD patients: lessons from the TORCH and UPLIFT studies.

Authors:  Marc Miravitlles; Antonio Anzueto
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-05-07

Review 8.  The safety of long-acting β2-agonists in the treatment of stable chronic obstructive pulmonary disease.

Authors:  Marc L Decramer; Nicola A Hanania; Jan O Lötvall; Barbara P Yawn
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-01-25

9.  Long-acting beta-agonists reduce mortality of patients with severe and very severe chronic obstructive pulmonary disease: a propensity score matching study.

Authors:  Nobuyuki Horita; Naoki Miyazawa; Satoshi Morita; Ryota Kojima; Naoko Kimura; Takeshi Kaneko; Yoshiaki Ishigatsubo
Journal:  Respir Res       Date:  2013-06-03

Review 10.  Defining disease modification in chronic obstructive pulmonary disease.

Authors:  David M G Halpin; Donald P Tashkin
Journal:  COPD       Date:  2009-06       Impact factor: 2.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.